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ABSTRACT
The age-specific impact on the survival of gastric cancer patients with distant 
metastasis is still unclear. In this study, we identified 11, 299 gastric cancer patients 
with distant metastasis between 2004 and 2013 from Surveillance, Epidemiology, 
and End Results population-based dataset. Patients were divided into young (≤60) 
and elderly groups (>60). Kaplan-Meier methods and multivariable Cox regression 
were used for the analysis of long-term survival outcomes and risk factors. There 
were significant differences between the two groups in terms of race, primary site, 
grade, histologic type, surgery, marital status and clinical T stage (P<0.05). The 
1- and 3-year cancer specific survival rates were 29.0% and 6.2% in young group 
and 22.8% and 4.8% in elderly group in both univariate (X2=116.430, P<0.001) 
and multivariate analysis (P<0.001). Young patients had significantly better 1- and 
3-year cancer specific survival than elderly patients in each T stage. Age was further 
validated as an independent survival factor in all T stages (T1, T2, T3, T4 and TX, 
P<0.05). In conclusion, age was an independent prognostic factor for gastric cancer 
patients with distant metastasis.
INTRODUCTION
Gastric cancer (GC) is the fifth most common 
malignancy worldwide and the third leading cause 
of cancer deaths [1-3]. Despite the improvements in 
diagnosis and treatment, the 5-year overall survival (OS) 
rate for advanced GC is still below 30% [4-5]. Age has 
been recognized as an important predictor of prognosis 
in many cancers [6-7]. The prevalence of GC increases 
with age, and the peak incidence is in old population of 
60-70 years [8-9]. Clarification of the relationship between 
age and GC survival could reveal the impact of age on 
cancer prognosis and improve treatment efficacy [10]. 
Some studies reported that young GC patients usually 
had advanced stage and undifferentiated tumors [11-12]. 
Song et al. [8] argued that the prognosis of GC varied with 
age, and young patients had a higher survival rate after 
surgery compared to elderly patients. Similar results were 
also found in Li's study [6], where young patients with 
colorectal cancer after surgery had a higher cancer specific 
survival (CSS) rate than elderly ones [6]. Although the 
survival and age at diagnosis in GC has been investigated 
[8-9, 13], age-specific impact on the survival in GC 
patients with distant metastasis (M1) is still unclear. In 
this study, we compared the pathological characteristics 
and prognostic outcomes of GC with M1 in young patients 
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with elderly ones based on Surveillance, Epidemiology, 
and End Results (SEER) population-based data.
RESULTS
Patient characteristics
We identified 11, 299 GC patients with M1 
diagnosed between 2004 and 2013 of the known age (≥18). 
In this study, we classified the patients into two groups: 
young (≤60) and elderly (>60) patients, including 7,128 
(63.09%) males and 4,171 (36.91%) females. The average 
follow-up period was 5 months. Patient demographics and 
pathological features were summarized in Table 1.
Characteristics of GC patients
There were significant differences between the two 
groups in terms of race, primary site, grade, histologic 
type, surgery, marital status and clinical T stage (P<0.05). 
Compared to elderly ones, young GC patients with M1 had 
more undifferentiated grade (66.0% VS 57.7%, P<0.05), 
more signet-ring cancer (35.0% VS 20%, P<0.05), and 
more stage T3 and T4 (9.8% VS 8.2%, 22.4% VS 19.0%; 
P<0.05). Except for married patients in young and 
elderly groups (58.8% and 58.9%), most of young ones 
were single/separated/unmarried (26.7%), while most of 
elderly were widowed (19.3%). As shown in Table 1, no 
significant differences were found between two groups in 
years of diagnosis (P=0.955) and sex (P=0.086).
Impact of age on GC survival outcomes
As shown in Tables 2 and 3 and Figure 2, the 1- and 
3-year CCS rates of GC were 29.0% and 6.2% in young 
group, and 22.8% and 4.8% in elderly group, which had 
significant difference using univariate (X2=116.430, 
P<0.001) and multivariate analysis (young group as 
ref., HR=0.808, 95%CI: 0.773~0.844, P<0.001). Year 
of diagnosis, sex, race, primary site, grade, histological 
type, surgery, marital status and clinical T stage were 
identified as significant risk factors for poor survival 
by univariate analysis (Table 2 and Figure 1, P<0.05). 
Female, black and American Indian/Alaska Native and 
widowed GC patients also had shorter survival periods 
(Table 2 and Figure 1). As shown in Table 2, the 1- and 
3-year CCS rates of patients in stage T1 (25.3% and 5.1%) 
were lower than that of in T2 (35.2% and 8.4%) and T3 
(34.7% and 8.8%), but higher than that in T4 (22.8% and 
4.9%) and Tx (21.0% and 3.8%). Multivariate analysis 
with Cox regression revealed that year of diagnosis, 
age, race, primary site, grade, histological type, surgery, 
marital status and pathological T stage were independent 
prognostic factors (Table 3, P<0.05).
Stratified analysis of age on GC survival based 
on T stage
We then further analyzed the effect of age on 1- and 
3-year CSS at each clinical T stage. We found that young 
patients had significantly better 1- and 3-year CSS than 
elderly patients in each T stage (Table 4, P<0.05). Age 
was further validated as an independent survival factor 
in multivariate Cox regression at T1 stage (elderly, HR: 
0.824, 95%CI: 0.742~0.915; P<0.001), T2 stage (elderly, 
HR: 0.756, 95%CI: 0.680~0.841; P<0.001), T3 stage 
(elderly, HR: 0.818, 95%CI: 0.713~0.938; P=0.004), T4 
stage (elderly, HR: 0.811, 95%CI: 0.742~0.886; P<0.001) 
and Tx stage (elderly, HR: 0.784, 95%CI: 0.733~0.838; 
P<0.001) patients (Table 4).
DISCUSSION
Despite advancement of diagnosis and treatment of 
GC, the prognosis remains poor with a 5-year OS of less 
than 30% in most countries [4-5, 14]. In China, GC is the 
second leading cause of cancer death, and the current 5 
year CSS is low because more than 80% of patients are 
diagnosed at an advanced stage [15-16]. Age is considered 
as one of the independent factors of several cancers [6-
9, 12]. Investigation of important prognostic factors of 
GC development could further understand and improve 
the treatment of the advanced disease. We identified 11, 
299 GC patients with M1 diagnosed between 2004 and 
2013 with a known age based on SEER population-based 
data. The current definition of elderly patients remains 
controversial. Some studies used the cutoff age of 50 
years, while others used 30 years or 45 years [6, 8-9, 17]. 
In this study, we divided GC patients into young (≤60) 
and elderly (>60) groups according to recent publications 
and the new age subsection-standard of the United Nations 
world health organization [8-9].
Recently, some studies have investigated the 
prognostic outcome of GC in young patients in 
comparison to the elderly, but yielded inconclusive 
results [18-19]. It has been suggested that young patients 
suffered worse survival due to the characteristics of 
themselves and different tumor behavior [20]. Chen et 
al. [9] reported that between 56 and 65 years have more 
favorable clinicopathologic characteristics and better CSS 
than the other groups in operable gastric cancer patients. 
While Song et al. [8] argued that the prognosis of GC 
varied with age, and young patients suffered a higher 
survival rate after surgery compared to elderly patients. 
In our study, we found that young GC patients with M1 
had a higher CCS rate compared to elderly ones. The 
1- and 3-year CCS rates of GC were 29.0% and 6.2% in 
young group and 22.8% and 4.8% in elderly group, which 
had significant difference by univariate (X2=116.430, 
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Table 1: Characteristics of GC patients with M1 from SEER database
Characteristic Total (n) Young (≤60) Elderly (>60) X2 P value
11299 5004 6295
Media follow up (month) 5 6 4
Years of diagnosis 0.003 0.955
 2004-2008 5549 2456(49.1) 3093(49.1)
 2009-2013 5750 2548(50.9) 3202(50.9)
Sex 2.953 0.086
 Male 7128 3113(62.2) 4015(63.8)
 Female 4171 1891(37.8) 2280(36.2)
Race 12.056 0.007
 White 8305 3617(72.3) 4688(74.5)
 Black 1434 664(13.3) 770(12.2)
 American Indian/Alaska 
Native 117 66(1.3) 51(0.8)
 Asian or Pacific 
Islander 1443 657(13.1) 786(12.5)
Primary site 25.720 0.001
 Cardia, NOS 3552 1520(30.4) 2032(32.3)
 Fundus of stomach 463 197(3.9) 266(4.2)
 Body of stomach 1021 470(9.4) 551(8.8)
 Gastric antrum 1708 739(14.8) 969(15.4)
 Pylorus 233 85(1.7) 148(2.4)
 Lesser curvature of 
stomach NOS 642 269(5.4) 373(5.9)
 Greater curvature of 
stomach NOS 380 190(3.8) 190(3.0)
 Overlapping lesion of 
stomach 1061 508(10.2) 553(8.8)
 Stomach, NOS 2239 1026(20.5) 1213(19.3)
Grade 107.261 0.000
 Well/Moderately 
differentiated 1929 668(13.3) 1261(20.0)
 Poorly differentiated/
Undifferentiated 6933 3301(66.0) 3632(57.7)
 Unknown 2437 1035(20.7) 1042(22.3)
Histologic type 341.140 0.000
 Adenocarcinoma, NOS 7338 2813(56.2) 4525(71.9)
 Carcinoma 951 441(8.8) 510(8.1)
 Signet ring cell 
carcinoma 3010 1750(35.0) 1260(20.0)
(Continued)
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Characteristic Total (n) Young (≤60) Elderly (>60) X2 P value
11299 5004 6295
Surgery 13.492 0.000
 Yes 1693 819(16.4) 874(13.9)
 No 9606 4185(83.6) 5421(86.1)
Marital status 1235.527 0.000
 Married 6649 2944(58.8) 3705(58.9)
 Divorced 978 455(9.1) 523(8.3)
 Widowed 1308 90(1.8) 1218(19.3)
 Single/separated/
unmarried 1927 1336(26.7) 591(9.4)
 Unknown 437 179(3.6) 258(4.1)
T stage 44.531 0.000
 T1 1814 730(14.6) 1084(17.2)
 T2 1784 809(16.2) 975(15.5)
 T3 1010 492(9.8) 518(8.2)
 T4 2316 1123(22.4) 1193(19.0)
 TX 4375 1850(37.0) 2525(40.1)
Table 2: Univariate survival analyses of GC patients with M1
Variable Total (n) 1-year CSS 3-year CSS Log rank x2 P value
Years of diagnosis 18.913 0.000
 2004-2008 5549 24% 4.8%
 2009-2013 5750 27.2% 6.3%
Sex 5.845 0.016
 Male 7128 26.3% 5.7%
 Female 4171 24.3% 4.9%
Age 116.430 0.000
 Young 5004 29.0% 6.2%
 Elderly 6295 22.8% 4.8%
Race 19.193 0.000
 White 8305 25.3% 5.2%
 Black 1434 23.1% 4.8%
 American Indian/
Alaska Native 117 23.2% 4.8%
 Asian or Pacific 
Islander 1443 29.8% 7.2%
Primary site 162.320 0.000
 Cardia, NOS 3552 29.2% 6.5%
(Continued)
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Variable Total (n) 1-year CSS 3-year CSS Log rank x2 P value
 Fundus of 
stomach 463 24.6% 4.8%
 Body of stomach 1021 25.5% 4.8%
 Gastric antrum 1708 27.4% 6.9%
 Pylorus 233 25.7% 6.4%
 Lesser curvature 
of stomach NOS 642 30.3% 7.0%
 Greater curvature 
of stomach NOS 380 26.0% 4.8%
 Overlapping 
lesion of stomach 1061 21.2% 4.1%
 Stomach, NOS 2239 18.9% 3.1%
Grade 66.031 0.000
 Well/Moderately 
differentiated 1929 32.3% 7.9%
 Poorly 
differentiated/
Undifferentiated
6933 24.9% 4.9%
 Unknown 2437 22.0% 4.9%
Histologic type 11.442 0.003
 Adenocarcinoma, 
NOS 7338 26.5% 6.0%
 Carcinoma 951 23.4% 5.1%
 Signet ring cell 
carcinoma 3010 23.8% 4.1%
Surgery 313.299 0.000
 Yes 1693 41.6% 11.7%
 No 9606 22.6% 4.2%
Marital status 119.561 0.000
 Married 6649 27.1% 5.9%
 Divorced 978 25.3% 3.3%
 Widowed 1308 17.7% 3.3%
 Single/separated/
unmarried) 1927 24.4% 5.8%
 Unknown 437 30.3% 7.0%
T stage 252.356 0.000
 T1 1814 25.3% 5.1%
 T2 1784 35.2% 8.4%
 T3 1010 34.7% 8.8%
 T4 2316 22.8% 4.9%
 TX 4375 21.0% 3.8%
Oncotarget97095www.impactjournals.com/oncotarget
Table 3: Multivariate Cox model analyses of prognostic factors of GC patients with M1
Variable HR 95%CI P value
Years of diagnosis 0.000
 2004-2008 Ref
 2009-2013 1.115 (1.070~1.161) 0.000
Sex 0.900
 Male Ref
 Female 1.035 (0.989~1.082) 0.136
Age 0.000
 Young Ref
 Elderly 0.808 (0.773~0.844) 0.000
Race 0.008
 White Ref
 Black 1.104 (1.037~1.175) 0.002
 American Indian/Alaska Native 1.139 (1.050~1.235) 0.002
 Asian or Pacific Islander 1.281 (1.045~1.570) 0.017
Primary site 0.000
 Cardia, NOS Ref
 Fundus of stomach 0.754 (0.709~0.801) 0.000
 Body of stomach 0.838 (0.751~0.935) 0.002
 Gastric antrum 0.842 (0.776~0.913) 0.000
 Pylorus 0.855 (0.798~0.917) 0.000
 Lesser curvature of stomach NOS 0.918 (0.792~1.062) 0.250
 Greater curvature of stomach NOS 0.750 (0.680~0.828) 0.000
 Overlapping lesion of stomach 0.854 (0.758~0.962) 0.009
 Stomach, NOS 0.950 (0.877~1.029) 0.207
Grade 0.001
 Well/Moderately differentiated Ref
 Poorly differentiated/Undifferentiated 0.880 (0.822~0.943) 0.000
 Unknown 1.044 (0.991~1.099) 0.103
Histologic type 0.003
 Adenocarcinoma, NOS Ref
 Carcinoma 0.945 (0.899~0.995) 0.30
 Signet ring cell carcinoma 1.003 (0.926~1.086) 0.946
Surgery 0.000
 Yes Ref
 No 0.638 (0.597~0.681) 0.000
Marital status 0.000
(Continued)
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Variable HR 95%CI P value
 Married Ref
 Divorced 1.076 (0.963~1.201) 0.196
 Widowed 1.234 (1.087~1.401) 0.001
 Single/separated/unmarried) 1.371 (1.211~1.552) 0.000
 Unknown 1.194 (1.061~1.344) 0.003
T stage 0.000
 T1 Ref
 T2 0.922 (0.868~0.979) 0.008
 T3 0.790 (0.740~0.842) 0.000
 T4 0.852 (0.785~0.942) 0.000
 TX 0.999 (0.944~1.056) 0.962
Figure 1: Survival curves in GC patients with M1 of different primary site, surgical treatment, marital status and T 
stage. (A) Primary site. X2 = 162.320, P<0.001; (B) Surgery. X2 = 313.299, P<0.001; (C) Marital status. X2 = 119.561, P<0.001; (D) T 
stage. X2 =252.356, P<0.001.
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P<0.001) and multivariate analysis (young group as ref., 
HR=0.808, 95%CI: 0.773~0.844) (P<0.001). It might be 
attributed to two main reasons. One could be explained 
by that the poor tolerance of extensive lymphadenectomy 
and standardized chemotherapy [21-22]. Clinicians are 
more likely to provide all remedial options for young 
patients since they have the better health condition and 
tolerance of chemotherapy [31]. The other reason was that 
young patients usually have better tolerance of surgery 
and better recovery [23-24]. Although some ones thought 
that oldness would another reason for affecting long-time 
survival, most of GC patients with distant metastasis died 
in 1 year and 3-year CSS was less than 10%.
Another interesting finding was that compared 
to elderly ones, young GC patients with M1 had 
characteristics of more poor or undifferentiated grade 
(66.0% VS 57.7%, P<0.05), more signet-ring cancer 
(35.0% VS 20%, P<0.05), more stage T3 and T4 (9.8% 
VS 8.2%, 22.4% VS 19.0%; P<0.05). Li et al. [6] also 
found young patients presented higher proportions of 
unfavorable behavior as well as advanced stage disease. 
In contrast, it was noted that that young patients suffered 
worse survival due to the personal characteristics and 
different tumor behavior [20]. It is well known that 
mucinous, signet-ring and poorly differentiated tumors 
tend to have a poorer prognosis compared to well and 
moderately differentiated tumors [25]. It is thought that 
gastric cancer results from a combination of environmental 
factors and an accumulation of specific genetic alterations. 
The genetic information of young patients is different from 
that which leads to sporadic carcinomas at an older age. 
And there is a tendency of late diagnosis of the disease in 
young patients [26-27].
In addition, we found that except for married ones 
in young and elderly groups (58.8% and 58.9%), most 
of young GC patients were single/separated/unmarried 
(26.7%), while most of elderly were widowed (19.3%) 
who had the shortest survivals. Li et al. [28] selected 
112, 776 colorectal cancer from SEER data and found 
unmarried patients were at greater risk of cancer specific 
mortality while widowed patients were at the highest risk 
of death than the other groups. Jin et al. [29] suggested 
that marriage had a protective effect against under-
treatment and cause-specific mortality in GC. It might 
be attributed to that widowed patients lack of social 
and connubial support [30] and psychosocial distress 
[31]. Widowed cancer patients showed more distress, 
depression, and anxiety than married counterparts, 
which might be attributed to that spouse could share 
the emotional burden and provide appropriate his/her 
support [32]. Depression or/and nonadherence have 
been found to be directly correlated to widowed cancer 
individuals [33]. It was reported that depression was 
related to VEGF, stimulating endothelial cell migration, 
Figure 2: Survival curves in GC patients with M1 of different age. (A) All patients. Young group vs. Elderly group, X2 = 
116.430, P<0.001; (B) T1 stage. Young group vs. Elderly group, X2= 9.817, P=0.002; (C) T2 stage. Young group vs. Elderly group, X2 = 
20.034, P<0.001; (D) T3 stage. Young group vs. Elderly group, X2 = 8.278, P=0.004; (E) T4 stage. Young group vs. Elderly group, X2 = 
22.753, P<0.001; (F) Tx stage. Young group vs. Elderly group, X2 = 51.779, P<0.001.
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proliferation and proteolytic activity in cancers [34]. 
Depression was strongly influenced by poor adherence 
to medical treatment.
This study has several limitations. First, the SEER 
database does not include information of therapeutic 
options such as detailed information of chemotherapy, 
targeted therapy, immunotherapy, recurrence and 
metastasis, which may also impact patients’ prognosis 
[35]. Second, the SEER database is lack of detailed 
description of the organ metastasis (liver, lung, 
bone or brain). Third, since most patients did not 
receive operation, we used clinical T stage instead of 
pathological T, which also may affect the analysis of 
prognosis in this study. Despite these limitations, we 
first reported that age was an independent prognostic 
factor in GC patients with M1. Further studies are 
needed to verify our findings.
MATERIALS AND METHODS
Study population and data extracted
The SEER database and SEER-stat software 
(SEER*Stat 8.3.2) were used to search GC patients with 
M1 between 2004 and 2013 with a known age (≥18). Years 
of diagnosis, sex, race, primary site, grade, histological 
type, surgery, marital status, clinical T stage, and CSS were 
extracted from the SEER database. Histological types were 
limited to adenocarcinoma (8140/3), carcinoma (8010/3; 
8020/3; 8021/3 and 8145/3) and signet ring cell carcinoma 
(8490/3). Survival time was calculated from the date of 
diagnosis to the date of cancer-specific death. The exclusion 
criterions included: age<18, no evaluation of histological 
type, multiple malignant neoplasms, died within 30 days or 
information on CSS and survival months unavailable.
Table 4: Univariate and multivariate analysis of age on CSS of different T stages
Variable Total (n) 1-year CSS 3-year CSS Univariate analysis Multivariate analysis
Log rank 
x2 P value HR (95%CI)
P 
value
T1 1814 9.817 0.002
Age
 Young 730 28.7% 5.2% Ref
 Elderly 1084 23.0% 5.0% 0.824(0.742~0.915) 0.000
T2 1784 20.034 0.000
Age
 Young 809 39.6% 9.4% Ref
 Elderly 975 31.5% 7.5% 0.756(0.680~0.841) 0.000
T3 1010 8.278 0.004
Age
 Young 492 38.8% 10.1% Ref
 Elderly 518 33.0% 7.5% 0.818(0.713~0.938) 0.004
T4 2316 22.753 0.000
Age
 Young 1123 24.7% 5.9% Ref
 Elderly 1193 20.9% 3.9% 0.811(0.742~0.886) 0.000
Tx 4375 51.779 0.000
Age
 Young 1850 24.5% 4.3% Ref
 Elderly 2525 18.5% 3.4% 0.784(0.733~0.838) 0.000
P values refer to comparison between two groups and were adjusted for years of diagnosis, sex, race, primary site, grade, 
histological type, surgery, marital status and clinical T stage.
Oncotarget97099www.impactjournals.com/oncotarget
Statistical analysis
Baseline characteristics were compared using the X2 
test for nominal variables. Survival curves were generated 
using Kaplan–Meier analyses, and the differences between 
the curves were analyzed by log-rank test. Cox regression 
models were built for analysis of risk factors for survival 
outcomes. Statistical analyses were performed using the 
statistical software package SPSS for Windows, version 
19.0 (SPSS Inc., Chicago, IL, USA). All P values were 
two-sided. P<0.05 was considered statistically significant.
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